glutathione pathway to triple negative cancer Oncology Letters Metabolic reprogramming in triple-negative breast
Metabolic reprogramming in triple negative breast cancer PMC Glutathione depletion and dihydroorotate dehydrogenase inhibition actuated ferroptosis augment to surmount triple negative breast cancer ScienceDirect Glutathione metabolism in cancer progression and treatment resistance PMC Glutathione Dependent Pathways in Cancer Cells
Pay in 4 interest-free payments of $6.37 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8



